...
首页> 外文期刊>癌と化学療法 >An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1
【24h】

An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1

机译:具有Virchow转移的不可切除的晚期胃癌,癌症腹水和直肠狭窄,有效地与BiwWeekly Paclitaxel和TS-1的组合化疗管理

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A 43-year-old woman who complained of abdominal fullness, appetite loss, and constipation was diagnosed as unresectable advanced schirrhous gastric cancer with left supra-clavicular lymph node metastases, massive ascites, rectal stenosis, and bilateral hydronephrosis due to peritoneal metastases. The biopsy specimen showed a poorly differentiated adenocarcinoma with signet-ring cells. After placement of the bilateral ureteral stents, she was treated with combined chemotherapy of biweekly paclitaxel (120 mg/m2, day 1, day 15) and TS-1 (80 mg/day, days 1-14 with 2-weeks rest). Subjective symptoms were relieved after one course of the chemotherapy. After 3 courses, computed tomography showed markedly reduced supra-clavicular lymph node metastases and no ascites. Radiographic and endoscopic examinations also demonstrated remarkable improvements in compliance of the gastric and rectal walls. These findings suggested that partial response on Response Evaluation Criteria in Solid Tumors (RECIST) was obtained.After the first course, the treatment was continued on an outpatient basis. There were no adverse effects over grade 2 throughout six courses of the chemotherapy. The biweekly paclitaxel and TS-1 chemotherapy may well be an effective treatment for advanced schirrhous gastric cancer with carcinomatous peritonitis.
机译:一名43岁的女性抱怨腹胀,食欲损失和便秘被诊断为不可切除的晚期乳糜育癌,左上爪淋巴结转移,大规模腹水,直肠狭窄和双侧肾内肾后分离引起的腹膜转移。活组织检查标本显示出具有符号环细胞的良差差异化的腺癌。在放置双侧输尿管支架后,她被双周紫杉醇(120mg / m2,第1天,第15天)和Ts-1(80毫克/天,2周休息时的80毫克/天)治疗。化疗一道后,主观症状得到缓解。在3个疗程之后,计算断层扫描显示出明显减少的术后淋巴结转移,没有腹水。射线照相和内窥镜检查还表现出胃直肠壁的符合性显着改善。这些发现表明,获得了实体肿瘤的响应评价标准的部分反应(重新入患者)。在第一课程中,治疗在外部依据。在化疗的六种课程中,在2年级的2级没有不利影响。双周紫杉醇和TS-1化学疗法可能是针对癌症腹膜炎的晚期乳糜胃癌的有效治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号